March 28th 2025
The product, called Akkermansia Probiotic contains pasteurized Akkermansia muciniphila AKK PROBIO, DigeSEB broad-spectrum digestive enzymes, and B-Complex vitamins.
Pendulum Therapeutics secures funding to help meet consumer demand
April 12th 2021The new venture capital funding will be used to increase the manufacturing and sales of Pendulum Glucose Control, ramp up the manufacturing of pipeline products to address the management of other chronic diseases, and conduct additional research, including clinical trials.
CRN launches its retailer and consumer education campaign on probiotics
April 2nd 2021The Council for Responsible Nutrition launched "Probiotics: What’s Inside is Alive," a campaign that educates retail buyers and customers about probiotics, to help retail buyers better curate their offerings, improves retailer handling including storage, and informs customers about their benefits.
Stratum Nutrition, Adare Biome enter U.S. distribution agreement for postbiotic ingredient
March 12th 2021Stratum Nutrition and Adare Biome entered into a North American distribution agreement for LBiome, a postbiotic for digestive health composed of two human-origin strains that have been heat-stabilized with its culture medium.
PanTheryx acquires TruBiotics probiotic brand from Bayer Healthcare LLC
March 8th 2021PanTheryx has acquired TruBiotics, a probiotic supplement brand, from Bayer HealthCare LLC. TruBiotics will be joining PanTheryx’s current brands and ingredient offerings, including Life’s First Naturals, daily colostrum, and prebiotics to create a full spectrum of nutrition supplements.
Recent review explores the relationship between the microbiome, immunity, and viral infection
February 26th 2021A recent review funded by the International Probiotics Association and authored by members of the association’s scientific committee, investigated the relationship between the gastrointestinal microbiome, the host immune system, and viral immunity.
North American research underway to study SIMBA capsules
February 25th 2021Lallemand Health Solutions and Nimble Science have announced the start of the first North American study of Nimble’s Small Intestine Microbiome Aspiration (SIMBA) Capsule, which passively samples the small intestine and transits the gastrointestinal tract.
Special issue of the journal Nutrients will focus on the benefits of bovine colostrum
February 11th 2021In the introductory paper, “Bovine colostrum: its constituents and uses,” the researchers describe the main constituents and quality control of bovine colostrum while sharing an overview of the use of cow colostrum in human and veterinary health and wellness.
AIDP receives patent for multi-ingredient prebiotic formula
February 3rd 2021AIDP, Inc. has secured U.S. patent 10,881,675 B2 on Jan. 5, 2021 for the combination of Actazin, a green or gold kiwi extract powder rich in the digestive enzyme actinidin, with PreticX xylooligosaccharide (XOS), a prebiotic.
Lallemand Health, NHP Research Alliance develop probiotic strain authenticity technology
January 28th 2021Lallemand Health Solutions and the Natural Health Product Research Alliance concluded a long-term partnership to implement the Purity-IQ Certification Program, to provide added assurance for probiotic strain authenticity.
ProBiotix Health expands in North America following licensing agreement with Genuine Health
January 26th 2021ProBiotix Health, a subsidiary of OptiBiotix Health PLC, has reached a non-exclusive licensing agreement for its branded LPLDL ingredient with Genuine Health for the development of a cardiovascular health product in Canada and the U.S.
Lonza, Body&Fit collaborate on specialty supplements using Duocap capsule technology
January 19th 2021Body&Fit, Glanbia Performance Nutrition’s direct-to-consumer brand, and Lonza are collaborating to expand Body&Fit’s nutrition, supplements and dietary solutions utilizing Lonza’s Duocap capsule portfolio and specialty nutrition ingredients.
New microbiome research finds associations between microbes, diet, and metabolic health
January 11th 2021A recent study called the Personalised Responses to Dietary Composition Trial (PREDICT 1) study, is among the largest and most detailed on the microbiome after performing deep metagenomic sequencing of 1,203 gut microbiomes from 1,098 individuals.